← Leaderboards
Koen Walter Van Besien
University Of Chicago
$3,211,623
Attributed
$4,556,074
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $693.1K · FY2006–23$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,556,074 · 5
By mechanism
R01$2,016,676 · 1
R21$1,656,976 · 3
K24$882,422 · 1
Top collaborators
- Thomas J Fahey3 shared
- Moonsoo M. Jin3 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Michael I Nishimura$19,220,002
- Hans Schreiber$12,391,832
- Peter Aidan Savage$14,017,592
- Ezra Cohen$7,350,375
- Victoria Lee$250,140
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchT-LymphocyteKineticsDesignNext GenerationPeptidesResearch PersonnelBusulfanTransplantationProgramsGenomicsMediatingConditioningLeukemiaHistocompatibilityImmune SystemImmunologyAreaChicagoHematopoieticFundingGraft Vs Leukemia EffectFacultyCellular Biology
Grant awards (15)
CAR T Cells for Advanced Thyroid Cancer$661,659
R01 · FY2023 · CA
CAR T Cells for Advanced Thyroid Cancer$661,926
R01 · FY2022 · CA
CAR T Cells for Advanced Thyroid Cancer$693,091
R01 · FY2021 · CA
Immunologic and pharmacologic studies in allotransplant$119,946
K24 · FY2011 · CA · contact PI
Immunologic and pharmacologic studies in allotransplant$57,841
K24 · FY2011 · CA · contact PI
Immunologic and pharmacologic studies in allotransplant$177,117
K24 · FY2010 · CA · contact PI
Immunologic and pharmacologic studies in allotransplant$176,466
K24 · FY2009 · CA · contact PI
Immunologic and pharmacologic studies in allotransplant$175,833
K24 · FY2008 · CA · contact PI
Busulfan conditioning: optimization, kinetics, genomics$264,975
R21 · FY2007 · CA · contact PI
Immunologic and pharmacologic studies in allotransplant$175,219
K24 · FY2007 · CA · contact PI
Busulfan conditioning: optimization, kinetics, genomics$285,683
R21 · FY2006 · CA · contact PI
Minor Histocompatilibity Vaccination After Allo-Transpl*$318,262
R21 · FY2004 · CA
TCR-gene modified t-cells for adaptive immunotherapy$228,750
R21 · FY2004 · CA
Minor Histocompatilibity Vaccination After Allo-Transpl*$330,556
R21 · FY2003 · CA
TCR-gene modified t-cells for adaptive immunotherapy$228,750
R21 · FY2003 · CA